MD Anderson Cancer Center Leukemia Group — Houston, Texas

MD Anderson Cancer Center Leukemia Group is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

MD Anderson Cancer Center Leukemia Group has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Anemia, Refractory, With Excess of Blasts.

Sponsors: Seagen Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MD Anderson Cancer Center Leukemia Group?

MD Anderson Cancer Center Leukemia Group has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MD Anderson Cancer Center Leukemia Group conducted?

MD Anderson Cancer Center Leukemia Group has 1 clinical trials on record. Their work covers Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Anemia, Refractory, With Excess of Blasts.

Is MD Anderson Cancer Center Leukemia Group accredited by Crixeo Health?

MD Anderson Cancer Center Leukemia Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MD Anderson Cancer Center Leukemia Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.